Table 7 Top 3 more than twofold elevated lipid elements of patients with severe acute pneumonia (SAP), acute pulmonary embolism (APE), or acute exacerbation of chronic pulmonary diseases (AECPD) with statistical significance, as compared with each other (p < 0.05 or less)
APE | p | Fold | |||
|---|---|---|---|---|---|
Compared with SAP | |||||
PG40:1 | 0.03 | 2.02 | |||
PG40:6 | 0.01 | 2.04 | |||
PS 18:0/22:3 | 0.01 | 2.07 | |||
SAP | p | Fold | AECPD | p | Fold |
|---|---|---|---|---|---|
Compared with APE | |||||
PC 39:3(18:0/21:3) | 0.03 | 2.79 | lysoPG20:0 | 0.01 | 2.65 |
PC 39:3(19:0/20:3) | 0.03 | 2.55 | Â | Â | Â |
SAP | p | Fold | APE | p | Fold |
|---|---|---|---|---|---|
Compared with AECPD | |||||
lysoPS15:1 | 0.05 | 2.53 | PS 18:0/22:3 | 0.00 | 2.43 |
| Â | Â | Â | PS 19:0/19:0 | 0.02 | 2.33 |
| Â | Â | Â | PS 20:3/22:6 | 0.04 | 2.13 |